Press Releases on March 6, 2025 - EIN Presswire - Press Release Distribution Service

Published on March 6, 2025 - 21:02 GMT

aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2025 - 21:01 GMT

United Abolitionists and Rotary District 6980 Donate Over 100,000 LEGOs for Children at The Howard Phillips Center

United Abolitionists and Rotary District 6980 donated over 100,000 LEGO pieces to The Howard Phillips Center, giving children a creative outlet. ORLANDO, FL, UNITED STATES, March 6, 2025 /⁨EINPresswire.com⁩/ -- United Abolitionists (UA), in …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on March 6, 2025 - 21:01 GMT

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Clinical data on track for Q2 2025 in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLC Expansion of investigator sponsored “window of opportunity” trial into newly diagnosed glioblastoma patients with EGFR aberrations expected in Q1 …

Distribution channels: Business & Economy, Technology ...

Published on March 6, 2025 - 21:01 GMT

Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today

WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and full-year 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its …

Distribution channels: Electronics Industry ...

Published on March 6, 2025 - 21:01 GMT

ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

– Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable clinical benefit in patients with HER2-positive gastric cancer in an oral presentation at 2025 ASCO GI – Presented Phase 1b/2 data …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2025 - 21:01 GMT

Asure Announces Fourth Quarter and Full Year 2024 Results

Reports Full Year 2024 Revenues of $119.8 million Full Year 2024 Recurring Revenues Grew 15% from Prior Year Recurring Revenues Grew to 96% of Total Revenues from 84% in the Prior Year AUSTIN, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. …

Distribution channels: Business & Economy, IT Industry ...

Published on March 6, 2025 - 21:01 GMT

Silvercrest Asset Management Group Inc. Reports Q4 and Year-End 2024 Results

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter and year ended December 31, 2024. Business Update Silvercrest …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 6, 2025 - 21:01 GMT

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the ...

FDA approves scPharmaceuticals’ supplemental New Drug Application to expand the FUROSCIX indication to include the treatment of edema in adult patients with chronic kidney disease, including nephrotic syndrome FUROSCIX is expected to be available for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...